Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: A randomized placebo controlled trial

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 8, 2015, Pages 1338-1344

  Togni, S ^a   Maramaldi, G ^a   Bonetta, A ^b   Giacomelli, L ^a   Di Pierro, F ^c  

^a INDENA S P A   (Italy)

^b Radiotherapy Unit   (Italy)

^c Velleja Research   (Italy)

Author keywords

Boswellia serrata; Mammary carcinoma; Radiotherapy skin damage

Indexed keywords

BOSWELLIC ACID; HYDROCORTISONE; PLACEBO; PLANT EXTRACT; SKIN CREAM; TRITERPENE;

ADJUVANT THERAPY; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BOSWELLIA SERRATA; BREAST CARCINOMA; CANCER RADIOTHERAPY; CLINICAL EVALUATION; COMPUTER ANALYSIS; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHOTOGRAPHY; PROPHYLAXIS; PRURITUS; RADIATION THERAPY ONCOLOGY GROUP SCALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SKIN BURNING SENSATION; SKIN COLOR; SKIN MANIFESTATION; SKIN TOXICITY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; AGED; BOSWELLIA; BREAST NEOPLASMS; MIDDLE AGED; RADIODERMATITIS;

ADULT; AGED; BOSWELLIA; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PLANT EXTRACTS; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; SKIN CREAM; TREATMENT OUTCOME; TRITERPENES;

EID: 84942243088     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. PIGNOL JP, OLIVOTTO I, RAKOVITCH E, GARDNER S, SIXEL K, BECKHAM W, VU TT, TRUONG P, ACKERMAN I, PASZAT L. A multicenter randomized trial of breast intensity- modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-2092.
2. HYMES SR, STROM EA, FIFE C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment. J Am Acad Dermatol 2006; 54: 28-46.
3. KANG HC, AHN SD, CHOI DH, KANG MK, CHUNG WK, WU HG. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiat Oncol J 2014; 32: 156-162.
4. AMMON HP. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 72: 1100-1116.
5. SFERRA R, VETUSCHI A, CATITTI V, AMMANNITI S, POMPILI S, MELIDEO D, FRIERI G, GAUDIO E, LATELLA G. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation. Eur Rev Med Pharmacol Sci 2012; 16: 1484-1498.
6. HAMIDPOUR R, HAMIDPOUR S, HAMIDPOUR M, SHAHLARI M. Frankincense (ru xiang; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med 2013; 3: 221-226.
7. POECKEL D, AND WERZ O. Boswellic acids: biological actions and molecular targets. Curr Med Chem 2006; 13: 3359-3369.
8. TAKAHASHI M, SUNG B, SHEN Y, HUR K, LINK A, BOLAND CR, AGGARWAL BB, GOEL A. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis 2012; 33: 2441-2449.
9. Eyre H, Hills J, Watkins D. Compositions containing boswellia extracts., Quest International B.V. Patent US 6, 589, 516B1; 2003.
10. CALZAVARA-PINTON P, ZANE C, FACCHINETTI E, CAPEZZERA R, PEDRETTI A. Topical Boswellic acids for treatment of photoaged skin. Dermatol Ther 2010; 23: S28-32.
11. VIYOCH J, TENGAMNUAY I, PHETDEE K, TUNTIJARUKORN P, WARANUCH N. Effects of trans-4-(aminomethyl) cy-clohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double- blind, controlled study. Curr Ther Res Clin Exp 2010; 71: 345-359.
12. FAJARDO LF, BERTHRONG M, ANDERSON RE. Radiation Pathology, Oxford University Press, 2001.
13. POTERA ME, LOOKINGBILL DP, STRYKER JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology 1982; 143: 775-777.
14. COX JD, STETZ J, PAJAK TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
15. PEDRETTI A, CAPEZZERA R, ZANE C, FACCHINETTI E, CALZAVARA-PINTON P. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study. Planta Med 2010; 76: 555-560.
16. GLEES JP, MAMEGHAN-ZADEH H, SPARKES CG. Effectiveness of topical steroids in the control of radiation dermatitis: a randomised trial using 1% hydrocortisone cream and 0.05% clobetasone butyrate (Eumovate). Clin Radiol 1979; 30: 397-403.
17. PURCHIARONI F, BEGINI P, MINNITI G, GALLINA S, DELLE FAVE G, MARIGNANI M. Glioblastoma multiforme and hepatitis B: do the right thing(s). Eur Rev Med Pharmacol Sci 2014; 18: 3629-3631.